14:30 | Welcome by Guy Sallet | |||
14:32 | Intro Christophe Andre -Van Hopplynus by Guy Sallet | |||
14:34 | Rec-Van Hopplynus: Live Inspiration for your new practice? | |||
14:39 | Intro Tom Rijssaert-Alcon by Guy Sallet | |||
14:41 | Rec-Alcon: Next advancement for Centurion Vision system : Active Sentry | |||
14:46 | Intro Novartis Luxturna by Joachim Van Calster | |||
14:47 | Rec-Novartis: Luxturna - Understanding gene therapy for inherited retinal dystrophies | |||
14:52 | Intro Jean-Frédéric Chibret -Théa Pharma by Guy Sallet | |||
14:54 | Rec-Théa Pharma: Education programme | |||
14:57 | Intro Novartis Lucentis by Joachim Van Calster | |||
14:58 | Rec-Novartis: Effectiveness and Safety of Lucentis in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study | |||
15:03 | Intro Karel Martens - FCI by Guy Sallet | |||
15:05 | Rec-FCI: FCI Newest innovative solutions | |||
15:10 | Intro Bayer by Joachim Van Calster | |||
15:12 | Rec-Bayer: Highlights nAMD by Dr. Edouard Duchateau, CHU Liège – Highlights DME by Dr. Freya Peeters, UZ Leuven | |||
15:21 | Intro GSK by Joachim Van Calster | |||
15:23 | GSK: Herpes zoster and GSK’s recombinant zoster vaccine, SHINGRIX: Introduction on HZ disease / Video / HZO: clinical aspects, incidence, treatment / Shingrix introduction | |||
15:38 | Intro Marc Van Schepdaal -Horus Pharma by Guy Sallet | |||
15:40 | Rec-Horus Pharma: Ophthalmology new innovations | |||
15:48 | Intro Novartis Beovu by Joachim Van Calster | |||
15:49 | Rec-Novartis: Beovu: introducing the next generation anti-VEGF | |||
15:54 | Closure of the session Guy Sallet – Joachim Van Calster | |||
15:55 | End of session - AOB Academic Session will start at 16:00 |